Gene Synthesis - Cost-effective measurement of enhanced R&D scale up and accelerate protein production

In vitro gene synthesis doesn’t require an initial physical template. Low to high-complex genes can be synthesized effectively without any error is one of the best advantages of a gene synthesis program. This technology evolving and shaping as a choice for many Life Science Industries post-COVID. The primary growth factor of adopting Gene Synthesis is;

Increased prevalence of chronic infectious diseases.
Rising adoption of Gene Therapy, CRISPR, and mRNA research.
Ease of multiplex PCR test development for diagnostic setup.
MICROBIAL STRAIN IMPROVEMENT: Microbes strain development for Pharma and Enzyme Engineering setup to enhance protein expression.
LEVERAGE MARKET POTENTIAL with Expansion of Synthetic Biology.
NO NEED OF INITIAL PHYSICAL TEMPLATE: Switching Gene Synthesis Program without the need for any Physical template.
TIME & COST LEADERSHIP to get any length of genes in a very short turnaround time with a lower cost.
OPERATIONAL EXCELLENCY: Reduction of optimization-lead time and substantially increase the dynamic capability of an organization at PIOLET TO PRODUCTION SCALE of protein production.
EASE OF MULTI-PRODUCT DESIGN: Expedite Demand and Supply with Multiple Project Design and TESTING with overall time reduction.

EUROFINS GENOMICS INDIA PRIVATE LIMITED offers a wide range of Gene Synthesis Services with Turn Around time of 2–3 weeks. Our expert technical and project management support will take care of the CUSTOMIZATION OF YOUR GENE.